Delivery Order SPE2DB24D8002-SPE2DB25FJNCV
Award Date
2/10/25
Potential Completion Date
2/11/25
Potential Value
$8.4K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,570.36, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to support the medical supply chain needs of the U.S. Department of Defense. The contract has a completion date of December 1, 2023, and is a Firm Fixed Price Delivery Order. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract...
This federal contract award, SPE2DB24D8003|SPE2DB25FJTKW, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a firm fixed price of $2,734.80 and a completion date of December 10, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The firm-fixed-price contract has a ceiling value of $15,991.71 and a period of performance through January 15, 2025. This award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, identified as SPE2DX15D8002|SPE2DX24F2TZ7, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,443.60 and an ultimate completion date of December 5, 2023. Dakota Drug, Inc. is a key supplier of...
This federal contract award, identified as SPE2DB24D8003 and SPE2DB25FJTDX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product Trelegy Ellipta, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $4,079.19 and a completion date of October 21, 2024. This award is not associated with any...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division. The $2,480.31 Firm Fixed Price Delivery Order contract is for the provision of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has an ultimate completion date of November 30, 2023 and is not designated as a set-aside award. Dakota Drug, Inc. is the prime contractor and has no listed...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,628.80, is for the delivery of Trelegy Ellipta 200-62.5-25 60s inhalers. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2023. The award is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a $6,399.12 firm-fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4566343564 units of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product. This delivery order falls under Dakota Drug's existing indefinite delivery contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which supports the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S prescription medication. The $5,011.42 firm fixed-price contract has a period of performance through November 8, 2024 and is not designated as a set-aside. Dakota Drug, Inc. holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which enables...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The $8,537.60 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products, which are likely used to treat respiratory conditions within the U.S. Armed Forces. As a long-standing prime contractor to the DLA Troop Support Medical, Dakota Drug, Inc. has a proven track record of providing a wide...